Evidence map›Paper›PMID 38992085›Full record

ArticleScientific reports2024

Molecular detection of sub-microscopic infections and Plasmodium falciparum histidine-rich protein-2 and 3 gene deletions in pre-elimination settings of South Africa.

Olukunle O Oyegoke, Olusegun P Akoniyon, Leah Maharaj, Taiye S Adewumi, Samson A Malgwi, Samuel A Aderoju, Abiodun J Fatoba, Matthew A Adeleke, Rajendra Maharaj, Moses Okpeku

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Local variability inMalariaWorld journal · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Olukunle O OyegokeDiscipline of Genetics, School of Life Sciences, University of KwaZulu-Natal, Durban, South Africa.
Olusegun P AkoniyonDiscipline of Genetics, School of Life Sciences, University of KwaZulu-Natal, Durban, South Africa.
Leah MaharajDiscipline of Genetics, School of Life Sciences, University of KwaZulu-Natal, Durban, South Africa.
Taiye S AdewumiDepartment of Molecular Biosciences, University of Kansas, Lawrence, KS, 66046, USA.
Samson A MalgwiDiscipline of Genetics, School of Life Sciences, University of KwaZulu-Natal, Durban, South Africa.
Samuel A AderojuDepartment of Mathematics and Statistics, Kwara State University, Ilorin, Nigeria.
Abiodun J FatobaDepartment of Genetics, Genomics and Bioinformatics, University of Tennessee Health Science Centre, Memphis, TN, 38016, USA.
Matthew A AdelekeDiscipline of Genetics, School of Life Sciences, University of KwaZulu-Natal, Durban, South Africa.
Rajendra MaharajMalaria Research Unit, South African Medical Research Council, Durban, South Africa.
Moses OkpekuDiscipline of Genetics, School of Life Sciences, University of KwaZulu-Natal, Durban, South Africa. OkpekuM@yahoo.com.

Funding

OKPEKU MOSES 120368
6 · The paper itself

Abstract

South Africa's efforts toward eliminating malaria have positioned the country in the pre-elimination stage. Imported and sub-microscopic cases still contribute to the persistence of malaria in regions of low transmission as identified in this study where diagnostics is built largely on the use of Rapid Diagnostic Test (RDT). However, the presence of Pfhrp2/3 gene deletion is known to interfere with the accuracy of diagnosis with the use of RDT. Malaria elimination and detection of Pfhrp2/3 gene deletion in the pre-elimination setting requires accurate molecular surveillance. With the core objective of this study being the determination of the presence sub-microscopic malaria cases and deleted Pfhrp2/3 gene markers, a total of 354 samples were collected from five districts of KwaZulu Natal, South Africa. These samples were prepared for molecular analysis using primers and PCR conditions specific for amplification of 18S rRNA and msp-1gene. Positive amplicons were analysed for the presence of Pfhrp2/3 and flanking genes, along with Sanger sequencing and phylogenetic studies. Out of 354 samples collected 339 were tested negative with PfHRP2 based RDTs. Of these Pfhrp2 and Pfhrp3 gene deletions were confirmed in 94.7% (18/19) and 100% (19/19) respectively. High migration rate (75%) among the study participants was noted and phylogenetic analysis of sequenced isolates showed close evolutionary relatedness with India, United Kingdom, Iran, and Myanmar and China isolates. Molecular-based test is recommended as an essential surveillance tool for malaria management programs as the target focuses on elimination.

Indexed as

Antigens, ProtozoanGene DeletionMalaria, FalciparumPlasmodium falciparumProtozoan ProteinsHumansPhylogenySouth AfricaAntigens, ProtozoanHRP-2 antigen, Plasmodium falciparumHRP3 protein, Plasmodium falciparumProtozoan Proteins

Identifiers

PMID38992085
PMCPMC11239831

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.